BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21160434)

  • 21. Characterization of cirrhotic nodules with gadoxetic acid-enhanced magnetic resonance imaging: the efficacy of hepatocyte-phase imaging.
    Chou CT; Chen YL; Su WW; Wu HK; Chen RC
    J Magn Reson Imaging; 2010 Oct; 32(4):895-902. PubMed ID: 20882620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance dynamic susceptibility-weighted contrast-enhanced perfusion imaging in the diagnosis of posterior fossa hemangioblastomas and pilocytic astrocytomas: initial results.
    Kumar VA; Knopp EA; Zagzag D
    J Comput Assist Tomogr; 2010; 34(6):825-9. PubMed ID: 21084895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined diffusion-weighted and dynamic contrast-enhanced imaging of patients with acute osteoporotic vertebral fractures.
    Biffar A; Sourbron S; Dietrich O; Schmidt G; Ingrisch M; Reiser MF; Baur-Melnyk A
    Eur J Radiol; 2010 Dec; 76(3):298-303. PubMed ID: 20580503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole-body MRI with assessment of hepatic and extraabdominal enhancement after administration of gadoxetic acid for staging of rectal carcinoma.
    Huppertz A; Franiel T; Wagner M; Püttcher O; Wagner J; Rief M; Schwenke C; Hamm B; Strassburg J
    Acta Radiol; 2010 Oct; 51(8):842-50. PubMed ID: 20698804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gadolinium-enhanced liver magnetic resonance imaging using a 2-point Dixon fat-water separation technique: impact upon image quality and lesion detection.
    Rosenkrantz AB; Mannelli L; Kim S; Babb JS
    J Comput Assist Tomogr; 2011; 35(1):96-101. PubMed ID: 21160433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of gadoxetic acid on quantitative diffusion-weighted imaging of the liver.
    Colagrande S; Mazzoni LN; Mazzoni E; Pradella S
    J Magn Reson Imaging; 2013 Aug; 38(2):365-70. PubMed ID: 23239165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinguishing hepatic metastasis from hemangioma using gadoxetic acid-enhanced magnetic resonance imaging.
    Motosugi U; Ichikawa T; Onohara K; Sou H; Sano K; Muhi A; Araki T
    Invest Radiol; 2011 Jun; 46(6):359-65. PubMed ID: 21427594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pediatric liver: focal masses.
    Siegel MJ; Chung EM; Conran RM
    Magn Reson Imaging Clin N Am; 2008 Aug; 16(3):437-52, v. PubMed ID: 18585597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rat model of reperfused partial liver infarction: characterization with multiparametric magnetic resonance imaging, microangiography, and histomorphology.
    Wu X; Wang H; Chen F; Jin L; Li J; Feng Y; DeKeyzer F; Yu J; Marchal G; Ni Y
    Acta Radiol; 2009 Apr; 50(3):276-87. PubMed ID: 19160078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of hyperintense nodules on precontrast T1-weighted MRI: utility of gadoxetic acid-enhanced hepatocyte-phase imaging.
    Chou CT; Chen YL; Wu HK; Chen RC
    J Magn Reson Imaging; 2011 Mar; 33(3):625-32. PubMed ID: 21563246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic and delayed contrast enhancement in upper abdominal MRI studies: comparison of gadoxetic acid and gadobutrol.
    Zizka J; Klzo L; Ferda J; Mrklovský M; Bukac J
    Eur J Radiol; 2007 May; 62(2):186-91. PubMed ID: 17367974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Staging hepatic fibrosis: computer-aided analysis of hepatic contours on gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced hepatocyte-phase magnetic resonance imaging.
    Goshima S; Kanematsu M; Kobayashi T; Furukawa T; Zhang X; Fujita H; Watanabe H; Kondo H; Moriyama N; Bae KT
    Hepatology; 2012 Jan; 55(1):328-9. PubMed ID: 21932401
    [No Abstract]   [Full Text] [Related]  

  • 33. Three-Tesla magnetic resonance elastography for hepatic fibrosis: comparison with diffusion-weighted imaging and gadoxetic acid-enhanced magnetic resonance imaging.
    Park HS; Kim YJ; Yu MH; Choe WH; Jung SI; Jeon HJ
    World J Gastroenterol; 2014 Dec; 20(46):17558-67. PubMed ID: 25516671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver MRI at 3.0 tesla: comparison of image quality and lesion detectability between single-source conventional and dual-source parallel radiofrequency transmissions.
    Hwang J; Kim YK; Park MJ; Lee MH; Kim SH; Lee WJ; Choi D
    J Comput Assist Tomogr; 2012; 36(5):546-53. PubMed ID: 22992605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization.
    Kubaska S; Sahani DV; Saini S; Hahn PF; Halpern E
    Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scirrhous hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging: emphasis on the differentiation of intrahepatic cholangiocarcinoma.
    Park MJ; Kim YK; Park HJ; Hwang J; Lee WJ
    J Comput Assist Tomogr; 2013; 37(6):872-81. PubMed ID: 24270108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
    Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
    J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection and characterization of focal hepatic tumors: a comparison of T2-weighted MR images before and after the administration of gadoxectic acid.
    Kim YK; Kwak HS; Kim CS; Han YM
    J Magn Reson Imaging; 2009 Aug; 30(2):437-43. PubMed ID: 19629973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T.
    Lo GG; Ai V; Chan JK; Li KW; Cheung PS; Wong TT; Ma M; Lee R; Chien D
    J Comput Assist Tomogr; 2009; 33(1):63-9. PubMed ID: 19188787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.